Argus Raises Amgen Price Target to $460
Amgen's stock price target has been raised to $460 from $375 by Argus, according to TipRanks.
The price target increase reflects a potential upside of approximately 22.6% from Amgen's current stock price.
The analysis is based on backtested results and may not reflect actual trading performance or economic factors that could impact the decision-making process.